您的位置:易推广 > 生物试剂/抗体/细胞 > 生化试剂 > 培养基 > 厦门慧嘉生物科技有限公司 > 产品展示 > 细胞因子 > B2GP1 Recombinant/重组人b-2糖蛋白

产品展示

B2GP1 Recombinant/重组人b-2糖蛋白

点击次数:230发布时间:2012/10/27 11:11:29

B2GP1 Recombinant/重组人b-2糖蛋白

更新日期:2024/10/16 16:00:43

所 在 地:美洲

产品型号:

简单介绍:B2GP1 Recombinant/重组人b-2糖蛋白

优质供应

详细内容

B2GP1 Recombinant/重组人b-2糖蛋白

产品编号:PRO-388
产品规格:5μg/20μg/1mg
 

慧嘉生物您实验身边的好伙伴

为客户提供“质量的产品”和“*优质的服务”
欢迎广大客户咨询,另有大量宣传海报和小礼品赠送。
网站:www.biohj.com  
联系电话:
    真:
Q Q:     
    箱:sale@biohj.com
 

 

Synonyms Beta-2-glycoprotein 1, Beta-2-glycoprotein I, Apolipoprotein H, Apo-H, B2GPI, Beta(2)GPI, Activated protein C-binding protein, APC inhibitor, Anticardiolipin cofactor, APOH, B2G1, BG, ?2GP-1, ?2 Glycoprotein-I.
Introduction ?2 Glycoprotein I (?2 GP I) is a serum protein with a single polypeptide chain consisting of 326 amino acids and having a molecular weight of 50 kDa. The protein is also known by the alternative name Apolipoprotein H (ApoH) which gives an indication of its phospholipid binding function.
Since the detection of ?2 Glycoprotein I as a target of antiphospholipid antibodies in 1990 the discussion about the clinical relevance of ?2 GP I is still controversial. It is well established that anticardiolipin antibodies are a very heterogeneous group and that ?2 GP I is only one of several potential targets for anticardiolipin antibodies. Nevertheless it is generally accepted that the binding of ?2 GP I to anionic lipids or surface is essential for the differential detection of anticardiolipin antibodies associated with autoimmune diseases (versus those associated with infectious diseases like syphilis, tuberculosis, AIDS, etc).
The close relationship of ?2 GP I antibodies and cardiolipin antibodies may indicate that the ?2 GP I isotypes have the same clinical relevance as the cardiolipin isotypes, where IgM, IgG and IgA autoantibodies have been observed and are routinely determined diagnostic targets.
B2GP1 antibodies and anticardiolipin antibodies can be detected in patients with arterial and venous thrombosis, recurrent fetal loss, thrombosis and SLE. The titers of anticardiolipin and anti-?2 GP I antibodies usually fluctuate sufficiently that they cannot be used for disease monitoring.
Description b2 Glycoprotein-I Human Recombinant produced in SF9 is a glycosylated, polypeptide chain containing 326 amino acids and having a molecular mass of 38,200 Dalton (excluding glycosylation), 45 kDa total mass.
B2GP1 is expressed with a -6xHis tag and purified by proprietary chromatographic techniques.
Source Sf9 insect cells.
Physical Appearance Sterile Filtered clear solution.
Formulation B2GP1 is supplied in 16mM HEPES buffer pH-7.2, 200mM NaCl, and 20% glycerol.
Immunological functions 1. Binds IgA & IgG-type human auto-antibodies, Auto-antibodies to ?2 glycoprotein I recognize conformation dependent and linear epitopes.
2. Standard ELISA test (checker-board analysis of positive/negative sera panels including a reference calibrator).
Applications Western-Blot with monoclonal anti-hexa-His-tag antibody and Goodpasture patient sera.
Coating concentration 0.5-1 μg/ml (depending on the type of ELISA plate and coating buffer).
Suitable for biotinylation and iodination.
Storage Conditions Store at 4°C if entire vial will be used within 2-4 weeks.
Store, frozen at -20°C for longer periods of time.
Avoid multiple freeze-thaw cycles.
Purity Greater than 90% as determined by SDS-PAGE.
Usage Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.

联系我们

联系人:陈先生

点击查看联系方式

企业档案

  • 会员类型:免费会员
  • 工商认证: 【已认证】
  • 最后认证时间:
  • 法人:
  • 注册号:****
  • 企业类型:代理商
  • 注册资金:人民币万

script>
在线咨询

提交